Nakayama M - Search Results

1

Plasma pteridine concentrations in patients with chronic renal failure.

Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T. Yokoyama K, et al. Among authors: nakayama m. Nephrol Dial Transplant. 2002 Jun;17(6):1032-6. doi: 10.1093/ndt/17.6.1032. Nephrol Dial Transplant. 2002. PMID: 12032193

2

[Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal].

Nakayama M, Ikeda M, Katoh N, Hayakawa H, Numata M, Otsuka Y, Yamamoto R, Yamamoto H, Yokoyama K, Kubo H, Kawaguchi Y, Hosoya T. Nakayama M, et al. Nihon Jinzo Gakkai Shi. 2002 May;44(4):396-401. Nihon Jinzo Gakkai Shi. 2002. PMID: 12073625 Japanese.

3

The negative Ca(2+) balance is involved in the stimulation of PTH secretion.

Yokoyama K, Kagami S, Ohkido I, Kato N, Yamamoto H, Shigematsu T, Nakayama M, Fukagawa M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Among authors: nakayama m. Nephron. 2002 Sep;92(1):86-90. doi: 10.1159/000064484. Nephron. 2002. PMID: 12187089

4

Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan.

Yamamoto H, Nakayama M, yamamoto R, Otsuka Y, Takahashi H, Kato N, Hayakawa H, Hasegawa T, Ikeda M, Yokoyama K, Kawaguchi Y, Mukai H, Hosoya T. Yamamoto H, et al. Among authors: nakayama m. Adv Perit Dial. 2002;18:135-8. Adv Perit Dial. 2002. PMID: 12402605

5

Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.

Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, Otsuka Y, Yokoyama K, Yamamoto R, Kawaguchi Y, Hosoya T. Nakayama M, et al. Adv Perit Dial. 2002;18:144-8. Adv Perit Dial. 2002. PMID: 12402607

6

[Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].

Nakayama M, Tanno Y, Otsuka Y, Takahashi H, Ikeda M, Katoh N, Yokoyama K, Yamamoto H, Tokutome G, Hosoya T. Nakayama M, et al. Nihon Jinzo Gakkai Shi. 2002 Oct;44(7):530-6. Nihon Jinzo Gakkai Shi. 2002. PMID: 12476589 Clinical Trial. Japanese.

7

Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.

Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Numata M, et al. Among authors: nakayama m. Perit Dial Int. 2003 Mar-Apr;23(2):116-22. Perit Dial Int. 2003. PMID: 12713076

8

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T. Tanno Y, et al. Among authors: nakayama m. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8. doi: 10.1093/ndt/gfg1025. Nephrol Dial Transplant. 2003. PMID: 12771313

9

Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.

Nakayama M, Sakai A, Numata M, Hosoya T. Nakayama M, et al. Am J Nephrol. 2003 Nov-Dec;23(6):390-4. doi: 10.1159/000074065. Epub 2003 Oct 10. Am J Nephrol. 2003. PMID: 14551463

10

Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration.

Nakayama M, Yoshimura K, Maruyama Y, Numata M, Hosoya T, Izumi G. Nakayama M, et al. Nephrol Dial Transplant. 2004 Jun;19(6):1664-5. doi: 10.1093/ndt/gfh198. Nephrol Dial Transplant. 2004. PMID: 15150373 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,242 results

Search Page